Cargando…
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy
OBJECTIVE: We report longitudinal data from 144 type III SMA pediatric and adult patients treated with nusinersen as part of an international effort. METHODS: Patients were assessed using Hammersmith Functional Motor Scale Expanded (HFMSE), Revised Upper Limb Module (RULM), and 6‐Minute Walk Test (6...
Autores principales: | Pera, Maria Carmela, Coratti, Giorgia, Bovis, Francesca, Pane, Marika, Pasternak, Amy, Montes, Jacqueline, Sansone, Valeria A., Dunaway Young, Sally, Duong, Tina, Messina, Sonia, Mizzoni, Irene, D’Amico, Adele, Civitello, Matthew, Glanzman, Allan M., Bruno, Claudio, Salmin, Francesca, Morando, Simone, De Sanctis, Roberto, Sframeli, Maria, Antonaci, Laura, Frongia, Anna Lia, Rohwer, Annemarie, Scoto, Mariacristina, De Vivo, Darryl C., Darras, Basil T., Day, John, Martens, William, Patanella, Katia A., Bertini, Enrico, Muntoni, Francesco, Finkel, Richard, Mercuri, Eugenio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351459/ https://www.ncbi.nlm.nih.gov/pubmed/34165911 http://dx.doi.org/10.1002/acn3.51411 |
Ejemplares similares
-
Different trajectories in upper limb and gross motor function in spinal muscular atrophy
por: Coratti, Giorgia, et al.
Publicado: (2021) -
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis
por: Coratti, Giorgia, et al.
Publicado: (2021) -
Nusinersen efficacy data for 24‐month in type 2 and 3 spinal muscular atrophy
por: Pane, Marika, et al.
Publicado: (2022) -
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy
por: Pera, Maria C., et al.
Publicado: (2017) -
Nusinersen improves walking distance and reduces fatigue in later‐onset spinal muscular atrophy
por: Montes, Jacqueline, et al.
Publicado: (2019)